Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.

Dotsey E, Ushach I, Pone E, Nakajima R, Jasinskas A, Argueta DA, Dillon A, DiPatrizio N, Davies H, Zlotnik A, Crompton PD, Felgner PL.

Sci Rep. 2017 Feb 17;7:42584. doi: 10.1038/srep42584.

2.

Dendritic Cell Regulation by Cannabinoid-Based Drugs.

Svensson M, Chen P, Hammarfjord O.

Pharmaceuticals (Basel). 2010 Aug 23;3(8):2733-2750. Review.

3.

Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk.

Chen J, Varga A, Selvarajah S, Jenes A, Dienes B, Sousa-Valente J, Kulik A, Veress G, Brain SD, Baker D, Urban L, Mackie K, Nagy I.

Sci Rep. 2016 Sep 22;6:33307. doi: 10.1038/srep33307.

4.

The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.

Bow EW, Rimoldi JM.

Perspect Medicin Chem. 2016 Jun 28;8:17-39. doi: 10.4137/PMC.S32171. eCollection 2016 Jun 28.

5.

Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.

Qiao CJ, Ali HI, Ahn KH, Kolluru S, Kendall DA, Lu D.

Eur J Med Chem. 2016 Oct 4;121:517-29. doi: 10.1016/j.ejmech.2016.05.044. Epub 2016 May 24.

PMID:
27318976
6.

Synthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.

Wang L, Mori W, Cheng R, Yui J, Hatori A, Ma L, Zhang Y, Rotstein BH, Fujinaga M, Shimoda Y, Yamasaki T, Xie L, Nagai Y, Minamimoto T, Higuchi M, Vasdev N, Zhang MR, Liang SH.

Theranostics. 2016 May 21;6(8):1145-59. doi: 10.7150/thno.15257. eCollection 2016 May 21.

7.

Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.

Walker VJ, Griffin AP, Hammar DK, Hollenberg PF.

J Pharmacol Exp Ther. 2016 Jun;357(3):537-44. doi: 10.1124/jpet.116.232553. Epub 2016 Mar 21.

PMID:
27000802
8.

Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation.

Gyires K, Zádori ZS.

Curr Neuropharmacol. 2016;14(8):935-951. Review.

PMID:
26935536
9.

Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands.

Kruk-Slomka M, Boguszewska-Czubara A, Slomka T, Budzynska B, Biala G.

Neural Plast. 2016;2016:9815092. doi: 10.1155/2016/9815092. Epub 2015 Dec 29.

11.

Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.

Netherland-Van Dyke C, Rodgers W, Fulmer M, Lahr Z, Thewke D.

J Cardiol Ther. 2015 Jul;3(2):53-63.

12.

β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.

Anderson GR, Aoto J, Tabuchi K, Földy C, Covy J, Yee AX, Wu D, Lee SJ, Chen L, Malenka RC, Südhof TC.

Cell. 2015 Jul 30;162(3):593-606. doi: 10.1016/j.cell.2015.06.056. Epub 2015 Jul 23.

13.

Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice.

Naderi N, Shafieirad E, Lakpoor D, Rahimi A, Mousavi Z.

Iran J Pharm Res. 2015 Winter;14(Suppl):115-20.

14.

Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling.

Almestrand S, Wang X, Jeppsson-Ahlberg Å, Nordgren M, Flygare J, Christensson B, Rössner S, Sander B.

PeerJ. 2015 Jun 30;3:e1056. doi: 10.7717/peerj.1056. eCollection 2015 Jun 30.

15.

MAP kinase cascades regulating axon regeneration in C. elegans.

Pastuhov SI, Hisamoto N, Matsumoto K.

Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(3):63-75. doi: 10.2183/pjab.91.63. Review.

16.

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.

Ogawa S, Hattori K, Sasayama D, Yokota Y, Matsumura R, Matsuo J, Ota M, Hori H, Teraishi T, Yoshida S, Noda T, Ohashi Y, Sato H, Higuchi T, Motohashi N, Kunugi H.

Sci Rep. 2015 Jan 15;5:7796. doi: 10.1038/srep07796.

17.

Individual differences in response to positive and negative stimuli: endocannabinoid-based insight on approach and avoidance behaviors.

Laricchiuta D, Petrosini L.

Front Syst Neurosci. 2014 Dec 22;8:238. doi: 10.3389/fnsys.2014.00238. eCollection 2014 Dec 22. Review.

18.

Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.

Griebel G, Pichat P, Beeské S, Leroy T, Redon N, Jacquet A, Françon D, Bert L, Even L, Lopez-Grancha M, Tolstykh T, Sun F, Yu Q, Brittain S, Arlt H, He T, Zhang B, Wiederschain D, Bertrand T, Houtmann J, Rak A, Vallée F, Michot N, Augé F, Menet V, Bergis OE, George P, Avenet P, Mikol V, Didier M, Escoubet J.

Sci Rep. 2015 Jan 6;5:7642. doi: 10.1038/srep07642.

19.

Endocannabinoid signalling and the deteriorating brain.

Di Marzo V, Stella N, Zimmer A.

Nat Rev Neurosci. 2015 Jan;16(1):30-42. doi: 10.1038/nrn3876. Review.

20.

Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Wyrofsky R, McGonigle P, Van Bockstaele EJ.

Expert Opin Drug Discov. 2015 Jan;10(1):17-36. doi: 10.1517/17460441.2014.966680. Epub 2014 Dec 9. Review.

Supplemental Content

Support Center